[Clinical and epidemiological features of COVID-19-related deaths in Tunisia before the emergence of VOCs (March 2020-February 2021)].
Caractéristiques cliniques et épidémiologiques des décès COVID-19 en Tunisie avant l’émergence des VOCs (mars 2020-février 2021).
COVID-19
Tunisia
epidemic
epidemiological surveillance
mortality
standardization
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2022
2022
Historique:
received:
22
05
2022
accepted:
02
09
2022
entrez:
7
3
2023
pubmed:
8
3
2023
medline:
9
3
2023
Statut:
epublish
Résumé
the purpose of this study was to describe the clinical and epidemiological features of COVID-19-related deaths in Tunisia notified at the ONMNE (National Observatory of New and emerging Diseases) between 2 we conducted a national prospective longitudinal descriptive study of data collected from the National Surveillance System of SARS-CoV-2 infection of the ONMNE, Ministry of Health. All COVID-19-related deaths that occurred in Tunisia between March 2020 and February 2021 were included in this study. Data were collected from hospitals, municipalities and regional health departments. Death notifications were collected from multiple data sources (triangulation): The Regional Directorate of Basic Health Care, the ShocRoom (Strategic Health Operations Center), public and private health facilities, the Crisis Unit of the Presidency of the Government, the Directorate for Hygiene and Environmental Protection, the Ministry of Local Affairs and the Environment, as part of the follow-up of confirmed cases by the ONMNE team, positive RT-PCR / TDR post mortem results. during this study, 8051 deaths were recorded, corresponding to a proportional mortality of 10.4%. The median age was 73 years, with an interquartile range of 17 years. Sex-ratio (M/F) was 1.8. The crude death rate was 69.1/100 000 inhabitants and fatality rate was 3.5%. The analysis of the epidemic curve showed 2 peaks of deaths on 29 prevention strategy based on public health measures must be reinforced by the rapid deployment of anti-COVID-19 vaccination, especially for people at risk of death.
Identifiants
pubmed: 36879635
doi: 10.11604/pamj.2022.43.172.35544
pii: PAMJ-43-172
pmc: PMC9984832
doi:
Types de publication
English Abstract
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
172Informations de copyright
Copyright: Sonia Dhaouadi et al.
Déclaration de conflit d'intérêts
Les auteurs ne déclarent avoir aucun conflit d´intérêt.
Références
Front Med (Lausanne). 2021 Jan 20;7:607786
pubmed: 33553204
BMJ. 2021 Feb 24;372:n415
pubmed: 33627311
Glob Health Res Policy. 2020 Dec 21;5(1):54
pubmed: 33349271
Aging Male. 2020 Dec;23(5):1416-1424
pubmed: 32508193
BMJ. 2021 Mar 31;372:n693
pubmed: 33789877
BMC Public Health. 2021 Jan 11;21(1):117
pubmed: 33430851
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1522-1527
pubmed: 33090978
J Infect. 2020 Oct;81(4):e18-e25
pubmed: 32634459
Rev Epidemiol Sante Publique. 2002 Apr;50(2):219-32
pubmed: 12011737
Int J Epidemiol. 2020 Jun 1;49(3):717-726
pubmed: 32086938
Clin Med (Lond). 2020 Mar;20(2):124-127
pubmed: 32139372
Nature. 2021 Jun;594(7862):259-264
pubmed: 33887749
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8232-8238
pubmed: 32767355
Thorax. 2018 Mar;73(3):286-289
pubmed: 28724637
Sante Publique. 2013 Sep-Oct;25(5):609-15
pubmed: 24418423
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 10;41(2):145-151
pubmed: 32064853
Ann Intern Med. 2003 Nov 4;139(9):715-23
pubmed: 14597455
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Popul Health Metr. 2020 Jul 3;18(1):3
pubmed: 32620133